Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioHarvest Sciences Inc. (BHST : NSDQ)

• Company Description    BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada. Number of Employees: 87

• Price / Volume Information    Yesterday's Closing Price: $7.22 Daily Weekly Monthly 20 Day Moving Average: 7,174 shares Shares Outstanding: 16.42 (millions) Market Capitalization: $118.59 (millions) Beta: 0.65 52 Week High: $7.86 52 Week Low: $4.66 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.77% -9.30% 12 Week 27.79% 7.49% Year To Date 16.83% 9.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1140 - 625 HOWE STREET - VANCOUVER,BC V6C 2T6 CAN ph: 646-863-2177 fax: - bhst@mzgroup.us https://bioharvest.com

• General Corporate Information    Officers Ilan Sobel - Chief Executive Officer Zaki Rakib - Chairman of the Board Ilana Belzer - Chief Operating Officer Alan Rootenberg - Chief Financial Officer Michal Sapir - Vice President Peer Information BioHarvest Sciences Inc. (CORR.) BioHarvest Sciences Inc. (RSPI) BioHarvest Sciences Inc. (CGXP) BioHarvest Sciences Inc. (BGEN) BioHarvest Sciences Inc. (GTBP) BioHarvest Sciences Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 09076J207 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 09/04/25 Share - Related Items Shares Outstanding: 16.42 Most Recent Split Date: 6.00 (0.03:1) Beta: 0.65 Market Capitalization: $118.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 4.28 EPS Growth vs. Year Ago Period: 62.82% vs. Previous Quarter: 23.53% Sales Growth vs. Year Ago Period: 47.08% vs. Previous Quarter: 8.00% ROE 06/30/25 - - 03/31/25 - -307.04 12/31/24 - -574.74 ROA 06/30/25 - - 03/31/25 - -33.21 12/31/24 - -56.92 Current Ratio 06/30/25 - - 03/31/25 - 0.51 12/31/24 - 0.55 Quick Ratio 06/30/25 - - 03/31/25 - 0.30 12/31/24 - 0.29 Operating Margin 06/30/25 - - 03/31/25 - -31.30 12/31/24 - -51.27 Net Margin 06/30/25 - - 03/31/25 - -31.30 12/31/24 - -51.27 Pre-Tax Margin 06/30/25 - - 03/31/25 - -31.13 12/31/24 - -51.24 Book Value 06/30/25 - - 03/31/25 - -0.05 12/31/24 - 0.08 Inventory Turnover 06/30/25 - - 03/31/25 - 3.63 12/31/24 - 3.72 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00

Powered by Zacks Investment Research ©